Finance

Lists
ENTX:NASDAQ
Entera Bio Ltd
US$3.22
0.00%
(0.00) 1D
US$3.22
+0.03% (+0.00100)
After hours
Closed: ኖቬም 12, 4:00:01 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENTX...
Open
US$3.20
High
US$3.24
Low
US$3.13
Mkt. cap
560.72 ሚ
Avg. vol.
514.87 ሺ
Volume
10.00
52-wk high
US$4.20
52-wk low
US$0.91
EPS
-US$0.35
Beta
1.48
Shares outstanding
174.14 ሚ
No. of employees
21
Open
US$3.20
High
US$3.24
Low
US$3.13
Mkt. cap
560.72 ሚ
Avg. vol.
514.87 ሺ
Volume
10.00
52-wk high
US$4.20
52-wk low
US$0.91
EPS
-US$0.35
Beta
1.48
Shares outstanding
174.14 ሚ
No. of employees
21
News stories
From web sources and news partners
Investing.com Australia
Investing.com Australia
·
ከ9 ደቂቃዎች በፊት
Nasdaq futures subdued as Nvidia upheaval roils AI trade By Reuters
Bloomberg.com
Bloomberg.com
·
ከ2 ሰዓቶች በፊት
Goldman Sees S&P 500 Rising 14% on Cheap Hyperscaler Valuations
WSJ
WSJ
·
ከ7 ሰዓቶች በፊት
Opinion | Pepper…and Salt
Barron's
Barron's
·
ከ2 ሰዓቶች በፊት
Stocks That Explain Today’s Market
About Entera Bio Ltd
CEO-
Employees21
Founded2009
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteenterabio.com
Analyst ratings
Based on 4 analysts giving stock ratings to ENTX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ENTX in the last 3 months.
Highest
Current US$3.22
US$11.00 (+241.61%)
Average
US$10.00 (+210.56%)
Lowest
US$9.00 (+179.50%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vamil Divan
Guggenheim
Buy
Maintained
US$11.00
+241.6%
11/09/2026
Patrick Dolezal
LifeSci Capital
Buy
Maintained
US$10.00
+210.6%
10/14/2026
Imogen Mansfield
Cantor Fitzgerald
Buy
Initiated
-
-
09/22/2026
David Risinger
Leerink Partners
Buy
Initiated
US$9.00
+179.5%
09/18/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$9.00
+179.5%
06/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.72 ሚ
2.25 ሚ
3.20 ሚ
4.92 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.32 ሚ
1.29 ሚ
1.36 ሚ
2.34 ሚ
Operating expense
3.04 ሚ
3.54 ሚ
4.56 ሚ
7.26 ሚ
Total operating expenses
3.04 ሚ
3.54 ሚ
4.56 ሚ
7.26 ሚ
Operating income
-3.04 ሚ
-3.54 ሚ
-4.56 ሚ
-7.26 ሚ
Other non operating income
-
-
-
-
EBT including unusual items
-3.02 ሚ
-3.50 ሚ
-7.31 ሚ
-15.60 ሚ
EBT excluding unusual items
-3.02 ሚ
-3.50 ሚ
-7.31 ሚ
-15.60 ሚ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.02 ሚ
-3.50 ሚ
-7.31 ሚ
-15.60 ሚ
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
26.00 ሺ
34.00 ሺ
-
-
Interest expense
-
-
-2.75 ሚ
-8.33 ሚ
Net interest expenses
26.00 ሺ
34.00 ሺ
-2.75 ሚ
-8.33 ሚ
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.04 ሚ
-3.53 ሚ
-4.55 ሚ
-7.26 ሚ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google መተግበሪያዎች